Primary sclerosing cholangitis: An experience from India

Primary sclerosing cholangitis (PSC) is considered to be rare in India. The aim of the present study was to investigate the incidence, clinical profile and outcome of PSC seen in a tertiary care centre. Over a period of 10 years (July, 1984‐June, 1994) 18 patients of PSC were diagnosed at cholangiography (14 patients by endoscopic retrograde cholangiopancreatography, two patients by percutaneous transhepatic cholangiography and two patients by both methods). The presence of secondary causes, such as choledocholithiasis, biliary tract surgery, congenital biliary tract anomalies, cholangiocarcinoma and pancreatic diseases, were excluded. These patients were evaluated retrospectively with respect to their clinical presentation, radiological findings, presence of associated idiopathic ulcerative colitis (IUC), treatment instituted and outcome. The mean (±s.d.) age at diagnosis of PSC was 39.0 (±16.1) years with a male: female ratio of 1.57:1. Nine (50%) patients had associated IUC. The diagnosis of IUC preceded that of PSC in all but one case. Fifteen (83.3%) patients had cholestatic jaundice at presentation, while three (16.7%) patients had asymptomatic rise of alkaline phosphatase. Three (16.7%) patients had recurrent cholangitis and five (27.8%) patients developed portal hypertension during the course of the disease. At cholangiography, intrahepatic radicles were involved in all and extrahepatic radicles in 12 (66.6%) cases. Patients were managed with steroids (n= 7), colchicine (n= 3), ursodeoxycholic acid (UDCA; n= 2) and methotrexate (n= 1), along with symptomatic measures. Mean duration of follow up available in 11 (61%) patients was 20.1 months (range: 1 month‐8 years). Four (36.4%) patients died. Steroids and colchicine did not have any effect while the one patient on UDCA and one on methotrexate showed improvement. In conclusion, in India PSC does not seem to be a rare entity. Its clinical profile and outcome are somewhat similar to those seen in Western countries.

[1]  S. Acharya,et al.  Primary sclerosing cholangitis in India , 1989, Gastroenterologia Japonica.

[2]  Y. Chawla,et al.  Ursodeoxycholic acid: a promising hepatoprotectant in cholestatic liver diseases. , 1994, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[3]  S. Robson,et al.  Primary sclerosing cholangitis. Requiem for biliary drainage operations? , 1994, Archives of surgery.

[4]  M. Kaplan,et al.  A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. , 1994, Gastroenterology.

[5]  Cohen Sa,et al.  Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. , 1993, The American journal of gastroenterology.

[6]  J. Siegel,et al.  Endoscopic management of primary sclerosing cholangitis: review, and report of an open series. , 1993, The American journal of gastroenterology.

[7]  T. Sauerbruch,et al.  Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial , 1992, Hepatology.

[8]  R. Chapman.  Aetiology and natural history of primary sclerosing cholangitis--a decade of progress? , 1991, Gut.

[9]  J. Senior,et al.  Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30‐month pilot study , 1991, Hepatology.

[10]  C. Majoie,et al.  Primary sclerosing cholangitis: a modified classification of cholangiographic findings. , 1991, AJR. American journal of roentgenology.

[11]  A. Malik,et al.  Extraintestinal manifestations of idiopathic ulcerative colitis. , 1991, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[12]  B. Portmann,et al.  Natural history and prognostic variables in primary sclerosing cholangitis. , 1991, Gastroenterology.

[13]  M. Kaplan,et al.  Treatment of primary sclerosing cholangitis with oral methotrexate. , 1991, The American journal of gastroenterology.

[14]  M. Kaplan.  Medical Approaches to Primary Sclerosing Cholangitis , 1991, Seminars in liver disease.

[15]  D. V. van Thiel,et al.  Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the abssence of inflammatory bowel disease? A study of sixty‐six subjects , 1990, Hepatology.

[16]  P. Grambsch,et al.  Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis , 1989, Hepatology.

[17]  A. Malik,et al.  Primary sclerosing cholangitis associated with chronic idiopathic ulcerative colitis. , 1986, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[18]  R. Chapman,et al.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.

[19]  R. Wiesner,et al.  Clinicopathologic features of the syndrome of primary sclerosing cholangitis. , 1980, Gastroenterology.

[20]  D. Winship.  Gastrointestinal disease: Pathophysiology, diagnosis and management , 1979 .